Alvotech (ALVO) Current Deferred Revenue (2020 - 2025)
Alvotech (ALVO) reported Current Deferred Revenue of $30.4 million for Q4 2025, up 90.01% on a YoY basis from $16.0 million in Q4 2024, and down 62.38% quarter-over-quarter from $80.7 million in Q3 2025.
Alvotech (ALVO) Current Deferred Revenue (2020 - 2025) Analysis & Trends
Alvotech has reported Current Deferred Revenue for 6 years, with the latest figure at $30.4 million in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue rose 90.01% year-over-year to $30.4 million; the trailing twelve-month figure through Dec 2025 stood at $30.4 million (up 90.01% YoY), and the FY2025 full-year result was $30.4 million, up 90.01% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $30.4 million, down from $80.7 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $90.1 million in Q2 2024, with the low at $16.0 million in Q4 2024.
- Historically, Current Deferred Revenue has averaged $61.4 million across 5 years, with a median of $59.7 million in 2023.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue slumped 78.19% — and 2025, when it soared 90.01%.
- Alvotech's Current Deferred Revenue stood at $44.8 million in 2021, then grew by 27.15% to $57.0 million in 2022, then gained by 28.49% to $73.3 million in 2023, then tumbled by 78.19% to $16.0 million in 2024, then soared by 90.01% to $30.4 million in 2025.
- The last three Current Deferred Revenue figures came in at $30.4 million (Q4 2025), $80.7 million (Q3 2025), and $60.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Alvotech | 12.16 Mn | -160.20 Mn | -22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.36 Mn |
| Sep 30, 2025 | 80.72 Mn |
| Jun 30, 2025 | 60.33 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 15.98 Mn |
| Sep 30, 2024 | 85.50 Mn |
| Jun 30, 2024 | 90.12 Mn |
| Mar 31, 2024 | 88.91 Mn |
| Dec 31, 2023 | 73.26 Mn |
| Jun 30, 2023 | 58.98 Mn |
| Mar 31, 2023 | 54.65 Mn |
| Dec 31, 2022 | 57.02 Mn |
| Jun 30, 2022 | 32.33 Mn |
| Dec 31, 2021 | 44.84 Mn |
| Dec 31, 2020 | 38.87 Mn |